Pricing Log in Create free account

Alector, Inc. (ALEC) vs Zentalis Pharmaceuticals, Inc. (ZNTL)

Alector, Inc. and Zentalis Pharmaceuticals, Inc. are both Biotechnology companies. Alector, Inc. and Zentalis Pharmaceuticals, Inc. are of similar size ($213.3M and $212.1M). Zentalis Pharmaceuticals, Inc. has the higher net margin (0.00% vs −850.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Alector, Inc. leads on 6 and Zentalis Pharmaceuticals, Inc. on 6.

Valuation

Metric ALEC ZNTL Biotechnology median
P/E n/m n/m 8.42
P/S 15.32 n/m 10.01
P/B n/m 1.12 2.21
Price to free cash flow n/m n/m 21.01
EV/EBITDA n/m 0.09 0.61
EV/Sales 4.17 n/m 9.41
Earnings yield (57.59%) (86.67%) (31.85%)
Free cash flow yield (74.56%) (79.76%) (24.58%)

Profitability

Metric ALEC ZNTL Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (912.40%) 0.00% 0.00%
Net margin (850.13%) 0.00% 0.00%
Free cash flow margin (1,142.55%) 0.00% 0.00%
Return on equity (385.11%) (66.75%) (56.36%)
Return on assets (42.15%) (49.22%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ALEC ZNTL Biotechnology median
Revenue growth (TTM) (82.91%) — 6.02%
EPS growth (last fiscal year) (13.01%) 18.03% 30.26%
Revenue growth, 5-year CAGR (0.05%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ALEC ZNTL Biotechnology median
Debt to equity (0.99) 0.00 0.00
Current ratio 5.26 4.82 4.72
Net debt to EBITDA 1.61 1.59 0.96

Dividend

Metric ALEC ZNTL Biotechnology median
Dividend yield — — 0.08%
Payout ratio — — —

Size

Metric ALEC ZNTL Biotechnology median
Market cap 213.27m 212.07m 132.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack